ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

BEEP Blackrock Emg

318.50
0.00 (0.00%)
24 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Blackrock Emg LSE:BEEP London Ordinary Share GB00B0BN1P96 ORD USD0.10
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 318.50 315.00 322.00 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

BlackRock Emerging Europe Portfolio Update

16/01/2018 3:33pm

UK Regulatory


 
TIDMBEEP 
 
BLACKROCK EMERGING EUROPE PLC (LEI - 549300OGTQA24Y3KMI14) 
 
All information is at 31 December 2017 and unaudited. 
 
Performance at month end with net income reinvested 
 
 
 
                          One      Three           One        Three        Five   *Since 
 
                        Month     Months          Year        Years       Years 30.04.09 
 
Sterling: 
 
Share price               1.5        3.3          20.9         81.7        41.3    147.1 
 
Net asset value           4.2        4.3          13.8         68.7        33.1    134.7 
 
MSCI EM Europe            5.4        4.1           9.9         48.7         4.5     79.8 
 
10/40(NR) 
 
US Dollars: 
 
Share price               1.4        4.1          32.3         57.6        17.6    125.6 
 
Net asset value           4.1        5.2          24.5         46.3        10.8    114.3 
 
MSCI EM Europe            5.4        5.0          20.3         29.0      -13.03     64.1 
 
10/40(NR) 
 
Sources: BlackRock, Standard & Poor's Micropal 
 
*BlackRock took over the investment management of the Company with effect from 
1 May 2009 
 
At month end 
 
US Dollar: 
 
Net asset value - capital only:                                                  496.38c 
 
Net asset value* - cum income:                                                   512.68c 
 
Sterling: 
 
Net asset value - capital only:                                                  366.93p 
 
Net asset value* - cum income:                                                   378.97p 
 
Share price:                                                                     353.38p 
 
Total assets^:                                                                   GBP136.1m 
 
Discount (share price to cum income NAV):                                           6.8% 
 
Net gearing at month end:                                                           3.5% 
 
Net yield^^^^:                                                                      1.7% 
 
Gearing range as a % of Net assets:                                                0-20% 
 
Issued Capital - Ordinary Shares^^                                            35,916,028 
 
Ongoing charges^^^                                                                  1.2% 
 
* Includes year to date net revenue equal to 12.04 pence per share. 
 
^ Total assets include current year revenue. 
 
^^ Excluding 5,000,000 shares held in treasury. 
 
^^^ Calculated as at 31 January 2017, in accordance with AIC guidelines. 
 
^^^^ Yield calculations are based on dividends announced in the last 12 months 
as at the date of release of this announcement, and comprise of the final 
dividend of 7.50 cents per share (announced on 28 March 2017, ex-dividend on 18 
May 2017). 
 
Sector                        Gross assets    Country                              Gross 
Analysis                               (%)    Analysis                            assets 
                                                                                     (%) 
 
Financials                            36.7    Russia                                54.1 
 
Energy                                32.1    Poland                                17.9 
 
Consumer Staples                       8.9    Turkey                                 7.9 
 
Telecommunication Services             7.5    Greece                                 6.6 
 
Health Care                            6.3    Hungary                                4.1 
 
Materials                              4.5    Ukraine                                3.6 
 
Information Technology                 2.9    Kazakhstan                             3.2 
 
Industrials                            1.2    Pan-Emerging Europe                    2.7 
 
Net current liabilities              (0.1)    Net current liabilities              (0.1) 
 
                                     -----                                         ----- 
 
                                     100.0                                         100.0 
 
                                     =====                                         ===== 
 
Short positions                      (1.7)                                         (1.7) 
 
 
 
Fifteen Largest Investments 
 
(in % order of Gross Assets as at 31.12.17) 
 
Company                                 Region of Risk                      Gross assets 
 
                                                                                     (%) 
 
Sberbank                                Russia                                       8.6 
 
Lukoil                                  Russia                                       8.5 
 
Gazprom                                 Russia                                       8.3 
 
PKO Bank Polski                         Poland                                       7.3 
 
Bank Pekao                              Poland                                       5.1 
 
Novatek                                 Russia                                       4.9 
 
Lenta                                   Russia                                       4.1 
 
Gedeon Richter                          Hungary                                      4.1 
 
PZU                                     Poland                                       3.8 
 
Rosneft Oil Company                     Russia                                       3.7 
 
National Bank of Greece                 Greece                                       3.4 
 
Mobile Telesystems                      Russia                                       3.2 
 
KazMunaiGas Exploration Production      Kazakhstan                                   3.2 
 
Alpha Bank                              Greece                                       3.1 
 
MHP                                     Ukraine                                      2.9 
 
Commenting on the markets, Sam Vecht and Christopher Colunga, representing the 
Investment Manager noted; 
 
The MSCI Emerging Europe 10/40 Index performed strongly in December, returning 
+5.4%* (in USD terms). The Company underperformed the index over the period, 
returning +4.1%* (in USD terms). 
 
Greece (+16.6%)** was the best performer led by banks as the second rescue 
package from Europe was approved in principal and on continued signs of 
strengthening domestic economy. 
 
Turkey (+13.2%)** performed strongly too with Lira strengthening 3.2% over the 
month.*** The Central Bank of Turkey hiked rates at its 14th December meeting 
by 50 bps to 12.75% in its late liquidity window, although less than the 
consensus expectations of 100 bps.*** 
 
In Central Europe, Hungary (+4.8%)**, Poland (+3.5%)** and Czech (+3.3%)** were 
also up as the domestic economies continue to benefit from a normalising 
European economic cycle. 
 
Russia (+3.0%)** was lagged as domestic stocks failed to react positively to an 
increasing oil price. Brent gained and closed the month at US$ 66.8 per barrel, 
which marked its highest level since 2014.*** The Central Bank of Russia cut 
rates by 50 bps (vs consensus expectations of 25 bps) at its 15th December 
meeting, continuing the monetary easing cycle and supporting the economy 
further.*** 
 
Focus on: Gedeon Richter 
 
Gedeon Richter is generic pharmaceuticals producer in Central Eastern Europe 
and Russia that is currently in the process of transforming itself into a 
specialty pharma company. In the past, it has largely developed APIs (Active 
Pharmaceutical Ingredients) and generics, but it is now starting to generate an 
increasing share of its profits from higher margin, innovative drugs both for 
women's health care and the central nervous system. 
 
Our investment case is based on the premise that these higher margin and faster 
growing specialty drugs will drive up both the company's revenues and margins. 
Management has already increased its 2017 operating margin guidance twice this 
year and we believe further upgrades are likely. The stock offers a very 
attractive high-double-digit earnings growth for the next couple of years and 
with strong cash conversion these earnings can either be distributed to 
shareholders or reinvested into the business via M&A transactions. With $300m 
in cash on its balance sheet and a strong management team the company appears 
well placed into the new year.* 
 
*Source: BlackRock, data as at end December 2017. 
 
**Source: BlackRock, MSCI, data as at end December 2017. 
 
***Source:  Bloomberg, JPM, data as at end December 2017. 
 
16 January 2018 
 
ENDS 
 
Latest information is available by typing www.blackrock.co.uk/beep on the 
internet, "BLRKINDEX" on Reuters, "BLRK" on Bloomberg or "8800" on Topic 3 (ICV 
terminal). Neither the contents of the Manager's website nor the contents of 
any website accessible from hyperlinks on the Manager's website (or any other 
website) is incorporated into, or forms part of, this announcement. 
 
 
 
 
END 
 

(END) Dow Jones Newswires

January 16, 2018 10:33 ET (15:33 GMT)

1 Year BLACKROCK EMERGING Chart

1 Year BLACKROCK EMERGING Chart

1 Month BLACKROCK EMERGING Chart

1 Month BLACKROCK EMERGING Chart

Your Recent History

Delayed Upgrade Clock